Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Subviral Agents01:29

Subviral Agents

596
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
596
Air-entraining Agents01:27

Air-entraining Agents

293
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
293
Masking and Demasking Agents01:19

Masking and Demasking Agents

3.7K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.7K
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

700
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
700
Spinal Nerves: Plexus II01:21

Spinal Nerves: Plexus II

2.5K
The plexuses of the lower body include the lumbar, sacral, and coccygeal plexuses, which innervate the abdomen, pelvis, legs, and coccygeal region. These plexuses control the transmission of sensory information and coordinate motor functions of the lower body.
The Lumbar Plexus
The lumbar plexus is situated within the lumbar region of the back and is primarily formed by the first four lumbar spinal nerves (L1 to L4). This plexus extends its branches into several nerves, including the...
2.5K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Nuclear disasters-in-waiting.

Science (New York, N.Y.)·2024
Same author

Laid to waste.

Science (New York, N.Y.)·2024
Same author

The bat man takes a stand.

Science (New York, N.Y.)·2023
Same author

Quatramer™ encapsulation of dual-targeted PI3-Kδ/HDAC6 inhibitor, HSB-510, suppresses growth of breast cancer.

Bioengineering & translational medicine·2023
Same author

Geriatric assessment measures are predictive of outcomes in chronic lymphocytic leukemia.

Journal of geriatric oncology·2023
Same author

Updates in Risk Stratification in Myelodysplastic Syndromes.

Cancer journal (Sudbury, Mass.)·2023

関連する実験動画

Updated: Feb 16, 2026

Chronic Social Defeat Stress in Early Adolescent Male Mice
07:06

Chronic Social Defeat Stress in Early Adolescent Male Mice

Published on: January 24, 2025

1.6K

神経毒剤を撃つ方法

Richard Stone

    Science (New York, N.Y.)
    |January 6, 2018
    PubMed
    まとめ

    No abstract available in PubMed .

    さらに関連する動画

    Author Spotlight: Understanding Adolescent Social Adversity Effects on Neurodevelopment in Mice
    07:15

    Author Spotlight: Understanding Adolescent Social Adversity Effects on Neurodevelopment in Mice

    Published on: March 15, 2024

    2.8K
    Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
    07:10

    Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

    Published on: March 7, 2011

    19.2K

    関連する実験動画

    Last Updated: Feb 16, 2026

    Chronic Social Defeat Stress in Early Adolescent Male Mice
    07:06

    Chronic Social Defeat Stress in Early Adolescent Male Mice

    Published on: January 24, 2025

    1.6K
    Author Spotlight: Understanding Adolescent Social Adversity Effects on Neurodevelopment in Mice
    07:15

    Author Spotlight: Understanding Adolescent Social Adversity Effects on Neurodevelopment in Mice

    Published on: March 15, 2024

    2.8K
    Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
    07:10

    Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

    Published on: March 7, 2011

    19.2K